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Isoprenoids increase bovine endometrial stromal cell tolerance to the 
cholesterol-dependent cytolysin from Trueperella pyogenes 
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Summary sentence: Mevalonate-derived isoprenoids, farnesyl and geranylgeranyl pyrophosphate, 
increase bovine endometrial stromal cell tolerance to the cholesterol-dependent cytolysin, pyolysin, 
which is secreted by the uterine pathogen Trueperella pyogenes. 
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Abstract 
Preventing postpartum uterine disease depends on the ability of endometrial cells to tolerate the 
presence of the bacteria that invade the uterus after parturition. Postpartum uterine disease and 
endometrial pathology in cattle is most associated with the pathogen Trueperella pyogenes. Trueperella 
pyogenes secretes a cholesterol-dependent cytolysin, pyolysin, which causes cytolysis by forming pores 
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in the plasma membrane of endometrial stromal cells. The aim of the present study was to identify cell-
intrinsic pathways that increase bovine endometrial stromal cell tolerance to pyolysin. Pyolysin caused 
dose-dependent cytolysis of bovine endometrial stromal cells and leakage of lactate dehydrogenase into 
supernatants. Cell tolerance to pyolysin was increased by inhibitors that target the mevalonate and 
cholesterol synthesis pathway, but not the mitogen-activated protein kinase, cell cycle, or metabolic 
pathways. Cellular cholesterol was reduced and cell tolerance to pyolysin was increased by supplying the 
mevalonate-derived isoprenoid farnesyl pyrophosphate, or by inhibiting farnesyl-diphosphate 
farnesyltransferase 1 or geranylgeranyl diphosphate synthase 1 to increase the abundance of farnesyl 
pyrophosphate. Supplying the mevalonate-derived isoprenoid geranylgeranyl pyrophosphate also 
increased cell tolerance to pyolysin, but independent of changes in cellular cholesterol. However, 
geranylgeranyl pyrophosphate inhibits nuclear receptor subfamily 1 group H receptors (NR1H, also 
known as Liver X receptors), and reducing the expression of the genes encoding NR1H3 or NR1H2 
increased stromal cell tolerance to pyolysin. In conclusion, mevalonate-derived isoprenoids increased 
bovine endometrial stromal cell tolerance to pyolysin, which was associated with reducing cellular 
cholesterol and inhibiting NR1H receptors. 
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Introduction 
Bacteria are ubiquitous in the uterus of dairy cattle after parturition, and infections of the endometrium 
cause metritis or endometritis in 20 to 40% of animals [1-3]. The cost of treating metritis, the 
subsequent infertility, and reduced milk production, is estimated to be about $2 billion per annum to 
the dairy industries of the EU and USA [1]. Postpartum uterine disease and endometrial pathology is 
most associated with the pathogen Trueperella pyogenes, which secretes a virulence factor, pyolysin, 
that forms pores in the plasma membrane of cells [4-6]. Endometrial stromal cells are particularly 
susceptible to cytolysis caused by pyolysin, and disruption of the epithelium after parturition exposes 
the underlying sensitive stroma to pyolysin [5, 7]. The defensive capability of a host against pathogens 
depends on resistance and tolerance [8, 9]. Resistance is the ability to reduce the pathogen burden, 
usually by immune cells killing the microbes. However, pyolysin does not provoke innate immune 
responses in endometrial or immune cells [5]. Tolerance is the ability to limit the impact of pathogens 
on health by tolerating a given microbial burden. Although tolerance to pathogens and their virulence 
factors, such as pyolysin, is thought to be vital for maintaining animal health, very few host-encoded 
tolerance mechanisms have been identified in any animal species [10]. 
After parturition, the uterus of dairy cattle contains a range of bacteria, including T. pyogenes, which 
come from the environment and the uterine microflora [1, 11-13]. Trueperella pyogenes is important 
because it is associated with the clinical severity of uterine disease and the extent of the subsequent 
infertility [1, 4, 13]. Furthermore, only the presence of T. pyogenes is correlated with the severity of 
endometrial pathology [4, 6]. Pyolysin (also known as PLO) is the major virulence factor of T. pyogenes, 
and pyolysin is a member of the cholesterol-dependent cytolysin family of pore-forming toxins [5, 14, 
15]. Cholesterol-dependent cytolysins are secreted from bacteria in a water-soluble form but convert 
into multimers in cholesterol-rich domains of the plasma membrane of mammalian cells, where they 
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create 30 to 50 nm diameter transmembrane pores (Fig. 1) [16-18]. These pores allow leakage of ions 
and cellular proteins across the plasma membrane, leading to cytolysis [16, 17, 19]. Bovine endometrial 
stromal cells are more sensitive to cytolysis caused by pyolysin than endometrial epithelial cells, 
neutrophils, monocytes or lymphocytes [5, 7]. 
Tolerance to pyolysin depends on the resilience of stromal cells to endure or cope with damage during 
infections. As pyolysin forms pores in the plasma membrane of cells, we reasoned that cell-intrinsic 
pathways might regulate the ability of cells to tolerate pyolysin. Plasma membranes contain 90% cellular 
cholesterol, and cholesterol constitutes almost half of the lipid molecules [20]. Cholesterol is 
synthesized by a series of enzymes, with the mevalonate pathway initially condensing two acetyl-CoA 
molecules to form acetoacetyl-CoA, which is then converted to 3-hydroxy-3-methyl-glutaryl-CoA (HMG-
CoA) by 3-hydroxy-3-methylglutaryl-CoA synthase 1, before 3-hydroxy-3-methylglutaryl-CoA reductase 
(HMGCR) yields mevalonate [21, 22]. A series of steps convert mevalonate to isoprenoids, with farnesyl 
diphosphate synthase (FDPS) yielding farnesyl pyrophosphate (Fig. 1). Farnesyl pyrophosphate is the key 
pathway branch point because it is a substrate for several enzymes, including farnesyl-diphosphate 
farnesyltransferase 1 (FDFT1, also known as squalene synthase) generating squalene, and 
geranylgeranyl diphosphate synthase 1 (GGPS1) forming geranylgeranyl pyrophosphate (Fig. 1). 
Squalene is converted to lanosterol by lanosterol synthase, and a series of enzymes ultimately lead to 
the synthesis of cholesterol [23]. Cholesterol homeostasis and the mevalonate pathway are regulated by 
sterols, isoprenoids and oxysterols, and their intracellular sensors [24, 25]. For example, cholesterol-
derived oxysterols and geranylgeranyl pyrophosphate bind the intracellular nuclear receptor subfamily 1 
group H member 3 and 2 receptors (NR1H3 and NR1H2; also known as Liver X receptors, LXRα and LXRβ, 
respectively) to regulate the expression of HMGCR, FDPS, FDFT1 and ABCA1 (ATP Binding Cassette 
Subfamily A Member 1) [26-29]. Another cellular pathways that might be important for cell tolerance to 
pyolysin is the mitogen-activated protein kinase (MAPK) pathway, as some pore-forming toxins activate 
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the cell stress molecules MAPK3/1, MAPK14 and MAPK8 (also known as ERK1/2, p38 and JNK, 
respectively) [30, 31]. Other important cell-intrinsic pathways, such as cell cycle regulators and the 
metabolic sensors, also influence plasma membrane turnover and cell viability [32-35]. Indeed, the risk 
of developing uterine disease is increased by the metabolic stress associated with milk production [36, 
37]. 
The aim of the present study was to identify cell-intrinsic pathways that increase bovine endometrial 
stromal cell tolerance to pyolysin. We screened molecules that modulate the MAPK, cell cycle, 
metabolism, and cholesterol synthesis pathways. Cell tolerance to pyolysin was increased by 
manipulating the cholesterol synthesis pathway, and particularly by the mevalonate-derived isoprenoids 
farnesyl pyrophosphate and geranylgeranyl pyrophosphate. Changes in endometrial stromal cell 
tolerance to pyolysin were associated with cholesterol and NR1H receptor dependent mechanisms. 
Methods 
Pyolysin 
The pyolysin plasmid (pGS59) was a generous gift from Prof BH Jost (University of Arizona, USA), and 
pyolysin protein was generated as described previously [5, 15]. The specific activity of pyolysin was 
628,338 HU/mg protein, as determined using a hemolysis assay. There was very little endotoxin 
contamination (1.5 EU/mg protein), as determined by a limulus amebocyte lysate assay (LAL endotoxin 
quantitation kit; Thermo Scientific, Hertfordshire, UK). 
Hemolysis assay 
To determine the activity of pyolysin, a hemolysis assay was performed using a 0.5% (v/v) suspension of 
horse red blood cells (Oxoid, Hampshire, UK) as described previously [5]. Optical density (OD450) was 
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measured using a microplate reader (POLARstar Omega; BMG Labtech, Offenburg, Germany). Hemolytic 
units were mathematically determined by 4-parameter modelling using the Solver function in Microsoft 
Excel. 
To examine for potential binding of pyolysin to farnesyl pyrophosphate or geranylgeranyl 
pyrophosphate, 100 HU/ml pyolysin was incubated for 1 h with 20 μM farnesyl pyrophosphate or 20 μM 
geranylgeranyl pyrophosphate, using 1 mM cholesterol as a positive control because cholesterol binds 
pyolysin [19]. A hemolysis assay was conducted after the 1 h incubation, as described above. 
Cell culture 
Isolation and culture of primary bovine endometrial stromal cells was performed as described previously 
[38, 39]. Briefly, uteri with no gross evidence of genital disease or microbial infections were collected 
from cattle after they were slaughtered and processed as part of the normal work of an abattoir. 
Postpartum cattle were not used to isolate endometrial cells because experiments would be 
confounded by the ubiquitous bacterial contamination of the uterus after parturition, existing 
endometrial inflammation and damage, and the metabolic stress of lactation [36-40]. Stromal cells were 
isolated by enzymatic digestion of the endometrium, sieving the cell suspension through a 40-μm mesh, 
and then adhesion of the stromal cells to culture plates, as described previously [38, 39]. Stromal cells 
were maintained at 37°C in humidified air with 5% carbon dioxide, using complete culture medium 
comprising RPMI-1640 (Gibco, Gaithersburg, MD, USA) with 10% fetal bovine serum (Biosera, 
Heathfield, UK), and 50 IU/ml penicillin, 50 µg/ml streptomycin and 2.5 µg/ml amphotericin B (all Sigma, 
Gillingham, UK). 
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Cell experiments 
Stromal cells were seeded at a density of 50,000 cells per well in 24-well tissue culture plates (TPP, 
Trasadingen, Switzerland), and cultured in complete culture medium using 1 ml/well to approximately 
70% confluence, as described previously [19, 39]. To avoid confounding cell-extrinsic factors in serum 
that might affect intracellular signaling pathways and cholesterol homeostasis, cells were then cultured 
in serum-free culture medium and treatments (see below) were applied in serum-free culture medium 
comprising RPMI-1640 with 50 IU/ml penicillin, 50 µg/ml streptomycin and 2.5 µg/ml amphotericin B, as 
described previously [5, 19]. 
To screen for molecules and pathways that might increase cell survival when cells were challenged with 
pyolysin, stromal cells were incubated for 24 h in serum-free medium containing vehicle, or molecules 
that target: MAPK (5 µM ERK Activation Inhibitor Peptide I (Calbiochem 328000) to inhibit MAPK3/1, 10 
µM JNK inhibitor II (Calbiochem 420128) to inhibit MAPK8, and 10 µM SB 203580 (Calbiochem 559398) 
to inhibit MAPK14, as used previously [38]); cell cycle (50 µM PNU112455A (Sigma SML0498) to inhibit 
cyclin dependent kinase (CDK)2 and CDK5, 80 µM roscovitine (Sigma R7772) to inhibit CDK1, CDK2, CDK5 
and CDK7, and 3 µM butyrolactone I (Sigma B7930) to inhibit CDK1, CDK2 and CDK5 [35, 41]); metabolic 
signaling pathways (10 µM AICAR (Cell Signalling 9944) to activate AMPK, 100 µM compound C 
(Calbiochem 171261) to inhibit AMPK, 2 µM Torin 1 (Cell Signalling 14379) to inhibit mTOR, 4 µM 
rapamycin (Cell Signalling 9904) to inhibit mTOR, 40 µM AKT inhibitor IV (Calbiochem 124038), and 2.8 
µM LY294002 (Cell Signalling 9901) to inhibit phosphoinositide 3-kinases [34, 42, 43]); or 48 h incubation 
with inhibitors for the cholesterol synthesis pathway (1 µM atorvastatin (Sigma PZ0001) to inhibit 
HMGCR [44]; 100 µM etidronate (Sigma P5248) and 10 µM alendronate (Sigma A4978), which inhibit 
human FDPS with IC50 of 80 μM and 0.5 μM, respectively [45]; 10 µM zaragozic acid (Sigma Z2626), 
which inhibits FDFT1 [19, 46]). Methyl-β-cyclodextrin (0.5 mM, Sigma C4555) was used as a positive 
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control because this cyclic oligosaccharide has an internal cavity that encapsulates hydrophobic sterols 
to efficiently deplete cholesterol from cells, which protect cells against cholesterol-dependent cytolysins 
[5, 18, 47]. The duration of treatment was based on our previous studies and preliminary experiments 
[5, 19, 31, 48]. After 24 h treatment, the supernatants were discarded and the cells were challenged 
with control serum-free medium or medium containing 100 HU/ml pyolysin for 24 h, and cell viability 
was determined by MTT assay. 
Having identified cholesterol synthesis as a target pathway for protecting cells against pyolysin, we 
sought to test cell tolerance using a brief 2 h challenge with pyolysin, because cell viability after a 24 h 
challenge with pyolysin might reflect cell repair or replication, as well as tolerance to pyolysin. To first 
determine the tolerance of stromal cells to pyolysin, and identify a suitable pyolysin challenge for 
subsequent experiments, cells were challenged for 2 h with control serum-free culture medium or 
medium containing a range of concentrations of pyolysin from 1 to 200 HU/ml, as indicated in Results. 
At the end of the 2 h challenge period, supernatants were collected for measurement of LDH leakage 
from cells, and cell viability was examined by MTT assay. 
To then examine the effect of components of the cholesterol synthesis pathway and mevalonate-
derived isoprenoids on cell tolerance to pyolysin, cells were treated for 48 h in serum-free culture 
medium or medium containing cell-soluble mevalonate (Sigma. 90469), farnesyl pyrophosphate (Sigma. 
F6892), squalene (Sigma. S3626), lanosterol (Sigma. L5768), geranylgeranyl pyrophosphate (Sigma, 
G6025), or methyl-β-cyclodextrin (Sigma, C4555), using the concentrations indicated in Results. Media 
were discarded and the cells were challenged for 2 h with control culture medium or medium containing 
100 HU/ml pyolysin. Alternatively, cells were transfected with scramble siRNA (ON-TARGETplus Non-
targeting siRNA #1; Dharmacon; gelifesciences.com) or siRNA targeting FDPS, GGPS1, NR1H2 or NR1H3, 
which were designed using Dharmacon’s siDESIGN Center (Supplemental Table S1). Briefly, duplex 
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complexes were formed by adding 100 pM of siRNA to 500 μl/well Opti-MEM I medium (Invitrogen, 
Waltham, MA) in 6-well plates (TPP), and then adding 7.5 μl Lipofectamine RNAiMAX Reagent 
(Invitrogen). Following 20 min incubation at room temperature, 250,000 exponentially growing cells 
were then seeded in 2.5 ml/well in complete culture medium for 48 h, and then 24 h in serum-free 
culture medium, prior to challenge for 2 h with control serum-free culture medium or medium 
containing 100 HU/ml pyolysin, and then examining cell viability and the leakage of LDH from cells into 
supernatants. 
Cell viability and LDH assay 
Cell viability was assessed by the mitochondria-dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT, Sigma) to formazan, as described previously [5, 49]. Briefly, once 
supernatants were collected, the remaining cells were incubated for 2 h in 250 μl/well serum-free 
culture medium containing 1 mg/ml MTT; the medium was then removed and the cells lysed with 250 
μl/well dimethyl sulfoxide (Sigma); and, optical density (OD570) measured using a POLARstar Omega 
microplate reader. We assumed that a reduction in OD570 was a reflection of cytolysis, as described 
previously for experiments using cholesterol-dependent cytolysins [5, 31, 50]. The correlation between 
MTT OD570 measurements and the number of live cells was confirmed previously using trypan blue 
exclusion and counting the number of live cells using a hemocytometer [5]. We defined 100% viability as 
the OD570 measurement for cells in control medium, and the percentage viability was calculated as the 
OD570 of pyolysin-treated cells relative to OD570 values for cells in control medium. 
Leakage of cellular LDH was measured in cell culture supernatants using the Lactate Dehydrogenase 
Activity Colorimetric Assay Kit (Biovision, California, USA), according to the manufacturer’s instructions. 
We assumed that increased LDH concentrations were a reflection of pore formation, as described 
previously for experiments using cholesterol-dependent cytolysins [31, 51]. For our experiments, we 
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defined 100% LDH leakage as the LDH concentration in the supernatants of cells challenged with 100 
HU/ml pyolysin, and the percentage LDH leakage was calculated as the LDH abundance of treated cells 
challenged with pyolysin relative to untreated cells challenged with pyolysin. 
Cholesterol measurement 
Cells were cultured to 70% confluence in 12-well tissue culture plates (TPP) and treated with 
mevalonate pathway intermediates or siRNA, as described above. At the end of the incubation period, 
cells were collected in 200 µl/well cholesterol assay buffer (Invitrogen) and stored in Eppendorf tubes at 
-20ºC. Prior to cholesterol quantitation, samples were defrosted at room temperature and sonicated for 
10 min in a sonicating water bath. Cellular cholesterol concentration was measured using the Amplex 
Red Cholesterol Assay Kit (Invitrogen), according to the manufacturer's instructions. To normalize the 
concentrations of cholesterol cellular, phospholipid was measured in the same samples using a 
phospholipid assay kit (Sigma Aldrich), according to the manufacturer’s guidelines. 
Quantitative PCR (qPCR) 
Cellular RNA was extracted using the RNeasy Mini Kit according to the manufacturer’s instructions 
(Qiagen, Crawley, UK). The RNA was quantified using a Nanodrop ND1000 spectrophotometer (Labtech, 
Ringmer, UK), and 1 μg of total RNA added to a genomic DNA elimination reaction, followed by 
conversion to cDNA (Quantitect Reverse Transcription Kit, Qiagen), according to the manufacturer’s 
instructions. Quantitative PCR was performed using exon-exon junction spanning primers (Supplemental 
Table S2) and the IQ5 system (Bio-Rad, Hemel Hempstead, UK). The starting quantity of mRNA was 
determined using standard curves generated from serial dilutions of pooled reference RNA with 
Quantifast SYBR green (Qiagen). The target and reference genes were analyzed in triplicate, and mRNA 
expression normalized to the ACTB and RPL19 reference genes (Supplemental Table S2) using the IQ5 
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system (Bio-Rad), with inter-run correlation and run-dependent differences corrected using qBase 
software on the IQ5 system (Bio-Rad), as described [52]. The reference genes did not differ in their 
expression with the treatments, and the reference genes were amplified with the same efficiency as the 
target genes. 
Western blotting 
The abundance of ABCA1 protein was used to verify the effectiveness of siRNA targeting NR1H receptors 
[29]. Cells were stored in RIPA buffer at -80°C for Western blotting. Cell lysate proteins were normalized 
to 1 µg/µl using the DC Assay (Bio-Rad) and separated (10 µg per lane) using 10% (vol/vol) SDS-
polyacrylamide gel electrophoresis. Pre-stained molecular weight markers were run in parallel lanes 
(Bio-Rad). After electrophoresis, proteins were transferred to a polyvinylidene difluoride membrane 
(Bio-Rad); nonspecific sites were blocked using a solution of 5% (wt/vol) bovine serum albumin (Sigma) 
in Tris-buffered saline (TBS) overnight at 4°C with gentle agitation. Membranes were probed with 
antibodies targeting ABCA1 (Abcam Cat# ab18180, RRID:AB_444302; Abcam, Cambridge, UK), which was 
selected based on recognition of immunoreactive proteins of 254 kDa (Supplemental Table S3), and 
protein loading was evaluated and normalized by examining ACTB (actin beta; Abcam Cat# ab8226, 
RRID:AB_306371; Abcam).  Primary antibodies were used at 1:500 dilutions in 5% (wt/vol) BSA in TBS for 
2 h with gentle agitation. After incubation, membranes were washed three times for 5 min in TBS and 
0.1% Tween 20 (pH 7.6). Membranes were then incubated in secondary horseradish peroxidase-
conjugated antibody (Cell Signalling Technology, Danvers, MA) in 5% (wt/vol) BSA in TBS for 1.5 h, and 
washed three times for 5 min in TBS and 0.1% Tween 20 (pH 7.6). Steady-state levels of immunoreactive 
proteins were visualized using enhanced chemiluminescence (Western C; Bio-Rad). The average peak 
densities of unsaturated bands were analyzed using Quantity-one software (Bio-Rad), and normalized to 
ACTB abundance. 
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Statistical analysis 
Data are presented as arithmetic mean and error bars represent SEM. The statistical unit was each 
animal from which cells were isolated. Statistical analyses were performed using GraphPad Prism 5.0.1 
and SPSS 20.0, with P < 0.05 considered statistically significant. Comparisons between two treatments 
were tested using Student’s t-test, and amongst several treatments using ANOVA, followed by Dunnett’s 
post hoc multiple comparison test. 
Results 
Endometrial stromal cell tolerance to pyolysin 
To initially screen for cellular pathways that may increase cell tolerance, stromal cells were treated with 
inhibitors or agonists that target the MAPK, cell cycle, metabolic and cholesterol pathways, prior to 
challenge with pyolysin. Treatments were prepared in serum-free culture medium using concentrations 
recommended by the manufacturers or in the literature. The MAPK and cholesterol pathways are 
established regulators of cell tolerance to cholesterol-dependent cytolysins [19, 30]. We considered cell 
cycle because cell replication requires plasma membrane turnover [35]. Furthermore, in preliminary 
experiments, 24 h treatment with a sub-lytic concentration of 0.25 HU/ml pyolysin, in serum-free 
medium, increased cell abundance (126 ± 5% of control, P < 0.05, t-test). The AMPK, mTOR, AKT and 
PI3K metabolic signaling pathways are associated with postpartum metabolic stress, postpartum uterine 
disease, and changes in endometrial resistance to pathogens [32-34, 36, 37, 43]. The cholesterol 
synthesis pathway was targeted using atorvastatin to inhibit HMGCR, etidronate and alendronate to 
inhibit FDPS, and zaragozic acid to inhibit FDFT1 [19, 44-46]. Methyl-β-cyclodextrin was used as a control 
because it depletes bovine endometrial stromal cell cholesterol, and is an established mechanism to 
increase cell tolerance to pyolysin [5, 31]. The inhibitors did not significantly reduce stromal cell viability 
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per se, except for roscovitine (53.6 ± 5.1% of control, P < 0.05, t-test) and Compound C (37.4 ± 1.6% of 
control, P < 0.01, t-test). The pyolysin challenge caused a 79% reduction in cell viability compared with 
cells in control medium, as determined by MTT assay (Fig. 2A). There was no significant effect on the 
viability of cells challenged with pyolysin associated with prior treatment with inhibitors or agonists for 
the MAPK, cell cycle, or metabolic signaling pathways (Fig. 2A). However, cell tolerance to pyolysin was 
increased by atorvastatin, zaragozic acid, and methyl-β-cyclodextrin. These results provide evidence that 
modulating the cholesterol synthesis pathway may improve the ability of cells to cope with pyolysin. 
The 24 h challenge with pyolysin might allow time for cell repair and replication, as well as reflecting cell 
tolerance to pyolysin. To specifically examine cell tolerance, bovine endometrial stromal cells were 
challenged with a range of concentrations of pyolysin for 2 h. This 2 h pyolysin challenge caused dose-
dependent cytolysis, as determined by MTT assay (P < 0.001, ANOVA; Fig. 2B), and dose-dependent 
formation of pores in the plasma membrane, as determined by leakage of LDH into the cell supernatants 
(P < 0.001, ANOVA; Fig. 2C). To seek cellular pathways that increase cell tolerance to pyolysin, in 
subsequent experiments we selected a 100 HU/ml pyolysin challenge because this caused a near 
maximal reduction in cell viability and leakage of LDH (Fig. 2B, C). 
Cholesterol synthesis pathway 
To take another approach to exploring which parts of the cholesterol synthesis pathway might be 
important for cell tolerance, we supplemented endometrial stromal cells with cell-permeable 
intermediates of the cholesterol synthesis pathway (Fig. 1). Cells were treated with mevalonate, farnesyl 
pyrophosphate, squalene, or lanosterol, prior to challenge with 100 HU/ml pyolysin (Fig. 3A-D). Cytolysis 
was examined using the MTT assay, and cell viability expressed as a percentage of the cells in control 
medium. Supplying mevalonate or squalene had no significant effect on cell tolerance to pyolysin (Fig. 
3A, C). However, supplying farnesyl pyrophosphate or lanosterol increased the tolerance of cells to 
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pyolysin, with ≥ 10μM farnesyl pyrophosphate providing complete tolerance to pyolysin (Fig. 3B, D). The 
effect of farnesyl pyrophosphate was interesting as inhibiting FDFT1 with zaragozic acid also increases 
the abundance of farnesyl pyrophosphate [53]; and zaragozic acid increased cell tolerance to pyolysin in 
Figure 1A. However, inhibiting FDFT1 also increases the abundance of geranylgeranyl-pyrophosphate 
[53], which is the isoprenoid derivate of farnesyl pyrophosphate (Fig. 1). Treating stromal cells with 
geranylgeranyl pyrophosphate resulted in a concentration-dependent increase in cell tolerance to 
pyolysin (Fig. 3E). One concern was that the cholesterol pathway intermediates added to cells might 
affect cell viability per se. However, there was no significant effect on endometrial stromal cell viability 
across the range of concentrations of mevalonate, farnesyl pyrophosphate, squalene, lanosterol or 
geranylgeranyl pyrophosphate used in the present study (Fig. 3A-E, black bars). 
To further explore the effect of the isoprenoids on cell tolerance, the effect on leakage of LDH from cells 
was evaluated using stromal cells treated for 24 h with 20 μM farnesyl pyrophosphate or 20 μM 
geranylgeranyl pyrophosphate, prior to challenge with 100 HU/ml pyolysin. Treatment with farnesyl 
pyrophosphate or geranylgeranyl pyrophosphate reduced the leakage of LDH by 96% and 56%, 
respectively, compared with cells in control medium challenged with pyolysin (Fig. 4 A). As expected, 
treatment with 0.5 mM methyl-β-cyclodextrin, used as a positive control, also reduced LDH leakage (Fig. 
4A). 
A potential confounding factor was that, although treatment media were removed prior to challenge 
with pyolysin, farnesyl pyrophosphate or geranylgeranyl pyrophosphate might bind to pyolysin directly 
to prevent cytolysis. To examine this possibility, pyolysin was incubated with 20 μM farnesyl 
pyrophosphate or 20 μM geranylgeranyl pyrophosphate for 1 h prior to addition of red blood cells, 
which are highly sensitive to pyolysin, with 10 HU pyolysin causing > 95% hemolysis [5, 31]. Cholesterol 
was used as a positive control because it is known to bind pyolysin, and, as expected, cholesterol 
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reduced the ability of pyolysin to cause hemolysis (P < 0.001, ANOVA; Fig. 4B). However, farnesyl 
pyrophosphate or geranylgeranyl pyrophosphate did not bind directly to pyolysin as there was no 
significant effect of farnesyl pyrophosphate or geranylgeranyl pyrophosphate on the ability of pyolysin 
to cause hemolysis (Fig. 4B). Together, the data from Figures 3B, 3E and 4A provide evidence that 
farnesyl pyrophosphate and geranylgeranyl pyrophosphate increase endometrial cell tolerance to 
pyolysin. 
Depleting FDPS and GGPS1 
The synthesis of farnesyl pyrophosphate depends on farnesyl diphosphate synthase (FDPS; Fig.1). To 
examine the effect of reducing endogenous farnesyl pyrophosphate siRNA was used to deplete FDPS 
mRNA expression (Fig. 5A). However, depleting FDPS did not significantly change cell viability or reduce 
the leakage of LDH from cells when cells were challenged with pyolysin (Fig. 5B, C). 
As farnesyl pyrophosphate is converted to geranylgeranyl pyrophosphate by geranylgeranyl diphosphate 
synthase 1 (GGPS1; Fig. 1), we wondered if increasing the abundance of endogenous farnesyl 
pyrophosphate by depleting GGPS1 mRNA might increase cell tolerance to pyolysin. Using siRNA to 
deplete GGPS1 mRNA (Fig. 5D) did not affect cell viability (Fig. 5E). However, depleting GGPS1 mRNA 
reduced the leakage of LDH from cells challenged with pyolysin by 72% (Fig. 5F). 
Endogenous farnesyl pyrophosphate and geranylgeranyl pyrophosphate abundance can also be 
increased by inhibiting FDFT1 with zaragozic acid [53]. Treatment of stromal cells with 10 μM zaragozic 
acid for 48 h increased cell viability when cells were challenged with 100 HU/ml pyolysin for 2 h, 
compared with untreated cells challenged with pyolysin (36% vs. 14% cell viability of control; P < 0.05, t-
test, n = 4). In addition, zaragozic acid also reduced the leakage of LDH into cell supernatants by 50 ± 
16% compared with untreated cells challenged with pyolysin (P <0.05, t-test, n = 4). Taken together, 
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these data provide further evidence for the importance of the mevalonate-derived isoprenoids in cell 
tolerance to pyolysin. 
Farnesyl pyrophosphate reduces cellular cholesterol 
We next considered potential mechanisms for farnesyl pyrophosphate increasing cell tolerance to 
pyolysin. The most obvious mechanism for increasing cell tolerance to cholesterol-dependent cytolysins 
is to reduce cellular cholesterol, as 90% of cholesterol is in cell plasma membranes [5, 20]. To examine 
the effect of the mevalonate-derived isoprenoids on cellular cholesterol, endometrial stromal cells were 
cultured for 48 h with 20 μM farnesyl pyrophosphate or 20 μM geranylgeranyl pyrophosphate, with 0.5 
mM methyl-β-cyclodextrin used as a positive control. The cells were collected to measure cellular 
cholesterol abundance, which was normalized to phospholipid abundance, as described previously [19]. 
Farnesyl pyrophosphate reduced cellular cholesterol, but geranylgeranyl pyrophosphate had no 
significant effect (Fig. 6A). Depleting FDPS mRNA expression using siRNA reduced cellular cholesterol, as 
might be predicted from the requirement for farnesyl pyrophosphate flux through the mevalonate 
pathway for cholesterol synthesis. However, depleting GGPS1 mRNA to increase farnesyl pyrophosphate 
abundance also reduced cellular cholesterol (Fig. 6B). Similarly, cholesterol abundance was reduced by 
treating cells with 10 μM zaragozic acid for 48 h to increase endogenous farnesyl pyrophosphate 
abundance, compared with cells in control medium (20.1 ± 1.3 vs 47.3 ± 2.5 μM cholesterol; P < 0.001, n 
= 4, t-test).  Together, these observations provide evidence for farnesyl pyrophosphate improving cell 
tolerance to pyolysin by reducing cellular cholesterol. 
NR1H receptors 
Despite the evidence that farnesyl pyrophosphate increases cell tolerance to pyolysin by reducing 
cellular cholesterol, how geranylgeranyl pyrophosphate protected cells against pyolysin was unclear, as 
geranylgeranyl pyrophosphate is not converted to farnesyl pyrophosphate [53]. However, 
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geranylgeranyl pyrophosphate inhibits NR1H3 and NR1H2 activity, whilst farnesyl pyrophosphate does 
not bind NR1H receptors [28, 54]. We therefore examined whether cell tolerance was affected by 
inhibition of NR1H3 (encoded by the gene NR1H3) or NR1H2 (encoded by the gene NR1H2). The 
expression of NR1H3 and NR1H2 mRNA was reduced by > 90% using siRNA (Fig. 7A, B). Reduction in the 
abundance of ABCA1 protein further confirmed the effectiveness of the siRNA (Fig. 7C, D; Supplemental 
Figure S1). The reduced expression of NR1H3 and NR1H2 mRNA did not significantly increase cell 
tolerance to pyolysin (Fig. 7E), but did reduce the leakage of LDH from cells challenged with pyolysin by 
68% and 55%, respectively (Fig. 7F). Taken together these data provide evidence that inhibiting NR1H 
receptor expression increases cell tolerance to pyolysin. 
Discussion 
Here we explored bovine endometrial stromal cell tolerance to the cholesterol-dependent cytolysin 
pyolysin. As well as addressing a biologically relevant problem for reproduction, the pyolysin dose-
dependent sensitivity of stromal cells provides a useful model to examine cell-intrinsic pathways that 
modulate cell tolerance to pathogens or their virulence factors. Endometrial stromal cell tolerance was 
dependent on the cholesterol synthesis pathway, but not the MAPK, cell cycle or metabolic pathways 
that we screened. In particular, cell tolerance to pyolysin was increased by the mevalonate-derived 
isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate. Reducing cellular cholesterol is 
known to increase cell tolerance to cholesterol-dependent cytolysins, and farnesyl pyrophosphate, but 
not geranylgeranyl pyrophosphate, reduced cellular cholesterol. However, geranylgeranyl 
pyrophosphate inhibits NR1H receptors, and using siRNA to target NR1H3 and NR1H2 increased cell 
tolerance to pyolysin. Together the results provide evidence that isoprenoids from the mevalonate 
pathway increase cell tolerance to pyolysin, and this was associated with reducing cellular cholesterol 
and inhibiting NR1H receptors. 
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In our initial screen for cell pathways that could protect against pyolysin, there was no significant effect 
of manipulating the MAPK, cell cycle, or metabolic pathways. However, manipulating the cholesterol 
synthesis pathway with atorvastatin or zaragozic acid markedly improved cell tolerance to pyolysin. 
Atorvastatin is a prototypical statin that inhibits HMGCR to reduce cellular cholesterol [55]. The 
protective role of atorvastatin in the present study supports previous findings that 1 μM atorvastatin 
protects bovine endometrial stromal cells against pyolysin by reducing cellular cholesterol [19]. 
Similarly, 1 μM simvastatin, which is another commonly used statin, protects human airway cells against 
the cholesterol-dependent cytolysin pneumolysin by reducing cellular cholesterol [56]. The increased 
cell tolerance to pyolysin in cells treated with zaragozic acid agrees with previous findings that inhibiting 
FDFT1 increases bovine endometrial stromal cell tolerance to pyolysin in a zaragozic acid concentration-
dependent manner [19]. Similarly, inhibiting FDFT1 with YM-53601 increased human airway cell 
tolerance to pneumolysin, as determined by leakage of ATP from the cytosol [56]. However, in both 
these studies the protective effects of inhibiting the cholesterol synthesis pathway were not solely 
attributable to reducing cellular cholesterol [19, 56]. Whilst inhibiting FDFT1 reduces the conversion of 
farnesyl pyrophosphate to squalene, zaragozic acid treatment of Hep G2 cells also yields farnesyl 
pyrophosphate and geranylgeranyl pyrophosphate [46]. So, we reasoned that an alternative mechanism 
for the increase in cell tolerance to pyolysin might be increased abundance of these mevalonate-derived 
isoprenoids. Unfortunately, measuring the concentration of isoprenoids inside cells was not practicable 
because isoprenoids are rapidly metabolized, and measurements using mass spectrometry are 
technically challenging. Furthermore, cell viability after a 24 h challenge with pyolysin might reflect cell 
repair or replication, as well as tolerance to pyolysin. We sought to more specifically examine cell 
tolerance using a brief 2 h challenge with pyolysin. Challenging bovine endometrial stromal cells with 
pyolysin reduced cell viability and increased the leakage of LDH in a concentration-dependent manner to 
provide a tractable model to explore cell-intrinsic pathways affecting tolerance. 
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To examine the role of the cholesterol synthesis pathway in cell tolerance, we supplied cells with 
pathway intermediates (Fig. 1). Mevalonate or squalene did not affect cell tolerance to pyolysin, but 
tolerance was increased by lanosterol, farnesyl pyrophosphate and geranylgeranyl pyrophosphate. To 
our surprise, supplying either farnesyl pyrophosphate or geranylgeranyl pyrophosphate reduced 
cytolysis and the leakage of LDH from cells challenged with pyolysin. However, reducing the supply of 
endogenous farnesyl pyrophosphate in cells using siRNA targeting FDPS, or using the bisphosphonates 
etidronate or alendronate to inhibit FDPS, had no significant effect on cell tolerance to pyolysin [45]. 
Conversely, increasing endogenous farnesyl pyrophosphate, using siRNA to target GGPS1 to prevent 
conversion of farnesyl pyrophosphate to geranylgeranyl pyrophosphate, reduced LDH leakage from cells 
challenged with pyolysin. Similarly, increasing endogenous farnesyl pyrophosphate and geranylgeranyl 
pyrophosphate by inhibiting FDFT1 with zaragozic acid increased cell tolerance and reduced LDH leakage 
by half. Together these results provide evidence that approaches to increase farnesyl pyrophosphate or 
geranylgeranyl pyrophosphate abundance also increased cell tolerance to pyolysin. 
Reducing cellular cholesterol is the most obvious mechanism by which altering isoprenoid abundance 
might increase cell tolerance to cholesterol-dependent cytolysins. Farnesyl pyrophosphate reduces 
cellular cholesterol in rat hepatocytes [55]. In the present study, supplying endometrial stromal cells 
with farnesyl pyrophosphate also reduced cholesterol. Furthermore, cholesterol was reduced by 
increasing endogenous farnesyl pyrophosphate using zaragozic acid to inhibit FDFT1, although inhibiting 
FDFT1 also reduces the synthesis of cholesterol by reducing the availability of squalene [46]. Similarly, 
siRNA targeting GGPS1 to prevent conversion of farnesyl pyrophosphate to geranylgeranyl 
pyrophosphate also reduced cellular cholesterol. From these results, we suggest that farnesyl 
pyrophosphate increases cell tolerance to pyolysin by reducing cellular cholesterol. 
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As supplying exogenous geranylgeranyl pyrophosphate had no effect on cellular cholesterol abundance, 
we considered an NR1H receptor-dependent mechanism for the action of geranylgeranyl pyrophosphate 
on cell tolerance. Although the endogenous agonists for NR1H receptors are oxysterols, geranylgeranyl 
pyrophosphate also inhibits NR1H3 and NR1H2, whereas farnesyl pyrophosphate does not [28, 54]. We 
reasoned that if geranylgeranyl pyrophosphate inhibits NR1H3 or NR1H2, then siRNA targeting their 
cognate genes NR1H3 and NR1H2, respectively, might increase cell tolerance. Although siRNA targeting 
NR1H3 or NR1H2 had no significant effect on cell viability, depleting NR1H3 or NR1H2 mRNA expression 
reduced the leakage of LDH from cells challenged with pyolysin by 68% and 55%, respectively. These 
data provide evidence for an unexpected link between NR1H receptor inhibition and cell tolerance. 
Future work might explore which NR1H genes and pathways are linked to cell tolerance. Both NR1H3 
and NR1H2 are constitutively active and have a wide range of target genes [28, 29]. Usually, activation of 
NR1H receptors leads to cholesterol efflux from cells, and in the present study, siRNA targeting NR1H3 
and NR1H2 reduced the abundance of the ABCA1 cholesterol efflux protein. So our finding that 
inhibition of NR1H receptors increases cell tolerance to pyolysin was surprising. However, NR1H 
receptors may also control the distribution of cholesterol in cells, and the susceptibility to pore-forming 
toxins may depend on the architecture of cholesterol-rich areas in plasma membranes [57]. Additional 
genes controlled by NR1H receptors that may also be important for cell tolerance to pore-forming toxins 
include genes associated with regulating inflammation, lipid metabolism, and carbohydrate metabolism 
[25]. Mevalonate-derived isoprenoids might also alter cell tolerance by affecting the abundance of 
coenzyme Q10 or dolichols, or protein farnesylation or geranylation; although, depletion of the 
isoprenoids did not increase cell sensitivity to pyolysin. It would be interesting to determine the effect of 
isoprenoids on the number and distribution of pores in the plasma membrane. However, this is not 
currently tractable in living cells because pyolysin pores are < 50 nm diameter, and protrude < 7 nm 
above the membrane surface, as determined by atomic force microscopy and neutron reflectometry in 
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artificial lipid membranes [48]. Similarly, we are aware that our endometrial cells are isolated from 
normal animals, rather than postpartum animals where other aspects of the postpartum period could 
influence how cells respond to pyolysin and isoprenoids. Irrespective of the underlying mechanisms, the 
translation of our findings might be possible by manipulating the cholesterol synthesis pathway in vivo. 
There is now a need for in vivo experiments using, perhaps using intrauterine infusion of a FDFT1 
inhibitor to increase farnesyl pyrophosphate and geranylgeranyl pyrophosphate, to confirm our present 
data and examine if isoprenoids can increase endometrial tolerance to pyolysin, in order to prevent 
postpartum uterine disease, such as metritis and endometritis. 
In conclusion, farnesyl pyrophosphate and geranylgeranyl pyrophosphate increased stromal cell 
tolerance to pyolysin. Increasing cell tolerance using approaches to increase farnesyl pyrophosphate was 
associated with reduced cellular cholesterol abundance. Surprisingly, geranylgeranyl pyrophosphate 
increased cell tolerance to pyolysin independently of cellular cholesterol abundance. However, 
geranylgeranyl pyrophosphate is an inhibitor for NR1H receptors, and reducing the expression of the 
NR1H3 and NR1H2 genes increased stromal cell tolerance to pyolysin. We suggest that mevalonate-
derived isoprenoids increase bovine endometrial stromal cell tolerance to pyolysin by reducing cellular 
cholesterol and inhibiting the NR1H receptors. 
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Figure 1. Cholesterol-dependent cytolysin. Schematic illustration of a pore formed by pyolysin in a 
cholesterol-rich domain in the plasma membrane, allowing leakage of ions and cytosolic molecules, such 
as lactate dehydrogenase (LDH). Cholesterol is derived from the mevalonate pathway that initially leads 
to the synthesis of the isoprenoid farnesyl pyrophosphate, with key enzymes indicated in red for 3-
hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and farnesyl diphosphate synthase (FDPS). 
Conversion of farnesyl pyrophosphate to squalene by farnesyl-diphosphate farnesyltransferase 1 
(FDFT1) is the first committed step of cholesterol synthesis, whilst geranylgeranyl diphosphate synthase 
1 (GGPS1) yields the isoprenoid geranylgeranyl pyrophosphate. PP – pyrophosphate 
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Figure 2. Cellular sensitivity to pyolysin. (A) Bovine endometrial stromal cells were incubated with 
culture medium containing vehicle, or molecules that target MAPK (5 µM ERK inhibitor, 10 µM JNK II 
inhibitor, 10 µM p38 inhibitor), cell cycle (50 µM PNU112455A, 80 µM roscovitine, 3 µM butyrolactone 
I), metabolic signaling pathways (10 µM AICAR, 100 µM compound C, 2 µM Torin 1, 4 µM rapamycin, 40 
µM AKT inhibitor IV, 2.8 µM LY294002), or the cholesterol synthesis pathway (1 µM atorvastatin, 100 
µM etidronate, 10 µM alendronate, 10 µM zaragozic acid), with 0.5 mM methyl-β-cyclodextrin as a 
positive control. Cells were then challenged with control medium () or medium containing 100 HU/ml 
pyolysin (), and cell viability was determined by MTT assay. Data are from at least 3 animals per 
treatment, and expressed as percent cell viability compared with cells in control medium. Data are 
presented as mean (SEM), and were analyzed by one-way ANOVA and Dunnett’s multiple comparison 
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post hoc test; values differ from vehicle, * P < 0.05, *** P < 0.001. (B-C) Bovine endometrial stromal cells 
were incubated for 2 h with control medium () or medium containing the indicated concentrations of 
pyolysin (). Cell viability was evaluated by MTT assay (B) and leakage of LDH into cell supernatants (C). 
Data are presented as mean (SEM); n = 4 animals. Data were analyzed by ANOVA with Dunnett’s 
multiple comparison test; values differ from control *** P < 0.001. 
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Figure 3. Farnesyl and geranylgeranyl pyrophosphate increase cell tolerance to pyolysin. Endometrial 
stromal cells were incubated with serum-free culture medium containing the indicated concentrations 
of (A) mevalonate, (B) farnesyl pyrophosphate, (C) squalene, (D) lanosterol or (E) geranylgeranyl 
pyrophosphate for 48 h and then challenged with control serum-free medium () or medium containing 
100 HU/ml pyolysin () for 2 h. Cell viability was determined by MTT assay and data expressed as the 
percent of control. Data are presented as mean (SEM); n = 3 or 4 animals for each treatment. Data were 
analyzed by one-way ANOVA and Dunnett’s multiple comparison post hoc test; ** P < 0.01, *** P < 
0.001. 
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Figure 4. (A) Endometrial stromal cells were incubated in control serum-free medium, or medium 
containing 20 μM farnesyl pyrophosphate, 20 μM geranylgeranyl pyrophosphate, or 0.5 mM methyl-β-
cyclodextrin, and then challenged with control serum-free medium () or medium containing 100 
HU/ml pyolysin () for 2 h. Cellular leakage was assessed measuring LDH in cell supernatants, and data 
expressed as percent of control challenged with pyolysin. Data are presented as mean (SEM); n = 3 
animals; ND, not detectable. Data were analyzed by one-way ANOVA and Dunnett’s multiple 
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comparison post hoc test; values differ from pyolysin treatment, * P < 0.05. (B) Dulbecco’s PBS (control), 
20 μM farnesyl pyrophosphate, 20 μM geranylgeranyl pyrophosphate, or 0.5 mM cholesterol as a 
positive control, were incubated with the indicated concentrations of pyolysin for 1 h in DPBS, and 
hemolysis evaluated by further incubation with 0.5 % (v/v) horse red blood cells for 1 h at 37°C. Data are 
presented as mean relative hemolysis in arbitrary units (AU); the group SEM was 0.13 AU; n = 3 
independent experiments. 
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Figure 5. RNA interference of FDPS and GGPS1. (A-F) Endometrial stromal cells were transfected with 
scramble siRNA or siRNA targeting FDPS or GGPS1 for 48 h. Cells were incubated for 24 h in serum-free 
medium and then challenged with control medium () or 100 HU/ml pyolysin () for 2 h. The mRNA 
expression of each cognate gene was measured by qPCR and normalized to two reference genes, ACTB 
and RPL19 (A, D). Data are presented as mean (SEM); n = 3 animals. Data were analyzed by Student’s t-
test; values differ from scramble, * P < 0.05, *** P < 0.001. Cell viability was quantified by MTT assay 
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and data expressed as percent of control (B, E), and supernatants were collected to measure the leakage 
of LDH from cells and data expressed as percent of control challenged with pyolysin (C, F). Data are 
presented as mean (SEM); n = 5 animals. Data were analyzed by one-way ANOVA and Dunnett’s multiple 
comparison post-hoc test; values differ from scramble challenged with pyolysin, *** P < 0.001, NS = not 
significant. 
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Figure 6. Cellular cholesterol. (A) Endometrial stromal cells were incubated in control serum-free 
medium, or medium containing 20 μM farnesyl pyrophosphate, 20 μM geranylgeranyl pyrophosphate, 
or 0.5 mM methyl-β-cyclodextrin for 48 h. (B) Cells were incubated for 48 h in medium containing 
scramble siRNA or siRNA targeting FDPS or GGPS1, or cultured with 0.5 mM methyl-β-cyclodextrin as a 
positive control. Cellular cholesterol was measured and normalized to phospholipid concentrations. 
Data are presented as mean (SEM); n = 4 independent animals for each experiment. Data were analyzed 
by one-way ANOVA and Dunnett’s multiple comparison post hoc test; values differ from control (A) or 
scramble (B), * P < 0.05, *** P <0.001. 
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Figure 7. NR1H receptors and cell tolerance. Endometrial stromal cells were transfected with scramble 
siRNA or siRNA targeting NR1H2 or NR1H3 for 48 h. The mRNA expression of each cognate gene was 
measured by qPCR and normalized to two reference genes, ACTB and RPL19 (A, B). Data are presented 
as mean (SEM); n = 3 animals. Data were analyzed by Student’s t-test; values differ from scramble, *** P 
< 0.001. (C) Endometrial stromal cells cultured with vehicle or transfected with scrambled siRNA, or 
siRNA targeting NR1H3 (siNR1H3) or NR1H2 (siNR1H2), were analysed by Western blot for ABCA1 and 
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ACTB abundance. (D) Densitometry data for ABCA1 were normalized to ACTB, and are presented as 
mean (SEM) from three independent experiments. Data were analysed by ANOVA and Dunnett’s 
pairwise multiple comparison t-test; values differ from scramble, * P < 0.05. (E, F) Endometrial stromal 
cells were transfected with scramble siRNA or siRNA targeting NR1H2 or NR1H3, incubated for 24 h in 
serum-free medium, and then challenged with control medium () or 100 HU/ml pyolysin () for 2 h. 
Cell viability was quantified by MTT assay (E), and supernatants were collected to measure leakage of 
LDH (F). Data are presented as mean (SEM); n = 5 animals. Data were analyzed by one-way ANOVA and 
Dunnett’s multiple comparison post-hoc test; values differ from scramble, *** P < 0.001. 
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